scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1020205144 |
P356 | DOI | 10.1186/1743-8454-5-9 |
P932 | PMC publication ID | 2387137 |
P698 | PubMed publication ID | 18439296 |
P5875 | ResearchGate publication ID | 5414245 |
P50 | author | Kaj Blennow | Q28321550 |
Mats Tullberg | Q47300678 | ||
P2093 | author name string | Pam Fredman | |
Jan-Eric Månsson | |||
Carsten Wikkelsö | |||
Magnus Tisell | |||
P2860 | cites work | Changes in cerebral blood flow during cerebrospinal fluid pressure manipulation in patients with normal pressure hydrocephalus: a methodological study | Q30928605 |
CSF monoamine metabolites, cholinesterases and lactate in the adult hydrocephalus syndrome (normal pressure hydrocephalus) related to CSF hydrodynamic parameters | Q33589450 | ||
Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. | Q34402201 | ||
CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy | Q35458189 | ||
Shunt related changes in somatostatin, neuropeptide Y, and corticotropin releasing factor concentrations in patients with normal pressure hydrocephalus. | Q35461127 | ||
Intracerebral microdialysis and CSF hydrodynamics in idiopathic adult hydrocephalus syndrome | Q35471536 | ||
Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values | Q40833195 | ||
Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid | Q42278005 | ||
A new procedure for determining ganglioside GD3 a potential glial cell activation marker in cerebrospinal fluid | Q42539235 | ||
Clinical parameters in 74 consecutive patients shunt operated for normal pressure hydrocephalus | Q43580506 | ||
Normal pressure hydrocephalus triggers intrathecal production of TNF-alpha | Q44529081 | ||
Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia | Q44571209 | ||
Association of deep white matter infarction with chronic communicating hydrocephalus: implications regarding the possible origin of normal-pressure hydrocephalus | Q45293694 | ||
MR imaging of cerebrospinal fluid dynamics in health and disease. On the vascular pathogenesis of communicating hydrocephalus and benign intracranial hypertension | Q48125621 | ||
Alterations in cerebrospinal fluid apolipoprotein E and amyloid beta-protein after traumatic brain injury. | Q48158131 | ||
Normal pressure hydrocephalus. Neuropathological study | Q48231799 | ||
Ventricular cerebrospinal fluid neurofilament protein levels decrease in parallel with white matter pathology after shunt surgery in normal pressure hydrocephalus | Q48244860 | ||
High cerebrospinal fluid concentration of glial fibrillary acidic protein (GFAP) in patients with normal pressure hydrocephalus | Q48447603 | ||
Normal pressure hydrocephalus: vascular white matter changes on MR images must not exclude patients from shunt surgery. | Q48681336 | ||
Cerebral blood flow and autoregulation in normal pressure hydrocephalus | Q48698561 | ||
Decreased cholecystokinin levels in cerebrospinal fluid of patients with adult chronic hydrocephalus syndrome | Q48754447 | ||
Neuropeptides in Cerebrospinal Fluid in Normal-Pressure Hydrocephalus and Dementia | Q48915634 | ||
Dutch Normal-Pressure Hydrocephalus Study: the role of cerebrovascular disease. | Q50534943 | ||
CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus. | Q51994953 | ||
Normal pressure hydrocephalus: psychiatric findings before and after shunt operation classified in a new diagnostic system for organic psychiatry. | Q52039309 | ||
Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively | Q52071642 | ||
Normal pressure hydrocephalus. Predictive value of the cerebrospinal fluid tap-test. | Q52078594 | ||
Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? | Q53212854 | ||
Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke. | Q64985564 | ||
Determination of delta-aminobutyric acid and other amino acids in cerebrospinal fluid of pediatric patients by reversed-phase liquid chromatography | Q69907581 | ||
Vascular risk factors and arteriosclerotic disease in idiopathic normal-pressure hydrocephalus of the elderly | Q70878576 | ||
Gait abnormality is not the only motor disturbance in normal pressure hydrocephalus | Q71125187 | ||
Regional cerebral blood flow in normal pressure hydrocephalus: diagnostic and prognostic aspects | Q72374907 | ||
[Incidence of surgery for hydrocephalus in adults surveyed: same number afflicted by hydrocephalus as by multiple sclerosis] | Q73939226 | ||
White matter changes in normal pressure hydrocephalus and Binswanger disease: specificity, predictive value and correlations to axonal degeneration and demyelination | Q74166042 | ||
Impaired wakefulness is associated with reduced anterior cingulate CBF in patients with normal pressure hydrocephalus | Q80845700 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | cerebrospinal fluid | Q54196 |
hydrocephalus | Q193003 | ||
idiopathic normal pressure hydrocephalus | Q28735834 | ||
P304 | page(s) | 9 | |
P577 | publication date | 2008-04-25 | |
P1433 | published in | Cerebrospinal Fluid Research | Q27720941 |
P1476 | title | Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus | |
P478 | volume | 5 |
Q64236352 | Causes of albuminocytological dissociation and the impact of age-adjusted cerebrospinal fluid protein reference intervals: a retrospective chart review of 2627 samples collected at tertiary care centre |
Q47846892 | Cerebrospinal Fluid Biomarkers as Predictors of Shunt Response in Idiopathic Normal Pressure Hydrocephalus: A Systematic Review |
Q35123209 | Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus |
Q42062882 | Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus |
Q36284128 | Cerebrospinal fluid biomarkers of infantile congenital hydrocephalus |
Q48201793 | Cerebrospinal fluid biomarkers profile of idiopathic normal pressure hydrocephalus. |
Q36577657 | Comparison of cerebrospinal fluid biomarkers between idiopathic normal pressure hydrocephalus and subarachnoid hemorrhage-induced chronic hydrocephalus: a pilot study. |
Q35231285 | Impact of cerebrospinal fluid shunting for idiopathic normal pressure hydrocephalus on the amyloid cascade |
Q36945742 | Influence of comorbidities in idiopathic normal pressure hydrocephalus - research and clinical care. A report of the ISHCSF task force on comorbidities in INPH. |
Search more.